Search - tctmd.com

Displaying 41 - 60 of 74

News Daily News

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

July 17, 2014

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Conference News ACC 2014

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

Jason Kahn

March 29, 2014

News Daily News

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Jason Kahn

January 15, 2014

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

News Daily News

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

December 10, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Presenter: Sripal Bangalore

October 27, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Daily News

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Caitlin E. Cox

May 03, 2013

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

News Daily News

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

Caitlin E. Cox

February 09, 2012

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

Advertisement

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

MISTRAL: No Lasting Benefit from Early Abciximab in STEMI Patients

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content